Breo Ellipta (vilanterol/fluticasone) matches Advair in RCT
www.pulmccm.org
Breo Ellipta (GlaxoSmithKline) is the first FDA-approved combination product with a once-daily long acting beta agonist (vilanterol) and inhaled corticosteroid (fluticasone).
Breo Ellipta (vilanterol/fluticasone) matches Advair in RCT
Breo Ellipta (vilanterol/fluticasone) matches…
Breo Ellipta (vilanterol/fluticasone) matches Advair in RCT
Breo Ellipta (GlaxoSmithKline) is the first FDA-approved combination product with a once-daily long acting beta agonist (vilanterol) and inhaled corticosteroid (fluticasone).